Norethisterone acetate versus norethisterone acetate combined with letrozole for the treatment of ovarian endometriotic cysts

A patient preference study

Simone Ferrero, Valentino Remorgida, Pier Luigi Venturini, Umberto Leone Roberti Maggiore

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

Objective To compare the efficacy of norethisterone acetate (NETA; group N) or letrozole combined with NETA (group L) in treating endometriotic ovarian cysts. Study design This patient-preference study included 20 patients in group N and 20 patients in group L. The primary aim of the study was to compare the volume of the endometriomas during and after treatment. The secondary outcome was the evaluation of the changes in pain symptoms during and after treatment. Results After six months of treatment, the volume of the endometriomas significantly decreased compared with baseline in both study groups; it was smaller in group L than in group N (p = 0.026). The rate of satisfied patients at six months of treatment was similar between the study groups (p = 0.451). No significant difference was reported between the two study groups in the amelioration of pain symptoms and in the incidence of adverse events. Conclusions Letrozole combined with NETA is more efficacious than NETA alone in reducing the volume of endometriotic cysts but in none of the 40 patients included in the study did the endometriomas disappear. The efficacy of aromatase inhibitors, however, should be balanced with the need to administer long-term treatment.

Original languageEnglish
Pages (from-to)117-122
Number of pages6
JournalEuropean Journal of Obstetrics and Gynecology and Reproductive Biology
Volume174
Issue number1
DOIs
Publication statusPublished - 2014

Fingerprint

letrozole
Ovarian Cysts
Patient Preference
Endometriosis
Therapeutics
Pain
Aromatase Inhibitors
Cysts
norethindrone acetate

Keywords

  • Endometriotic ovarian cysts
  • Letrozole
  • Norethisterone
  • Patient satisfaction

ASJC Scopus subject areas

  • Obstetrics and Gynaecology
  • Reproductive Medicine

Cite this

Norethisterone acetate versus norethisterone acetate combined with letrozole for the treatment of ovarian endometriotic cysts : A patient preference study. / Ferrero, Simone; Remorgida, Valentino; Venturini, Pier Luigi; Leone Roberti Maggiore, Umberto.

In: European Journal of Obstetrics and Gynecology and Reproductive Biology, Vol. 174, No. 1, 2014, p. 117-122.

Research output: Contribution to journalArticle

@article{24852d284acb42c2ab1d3b0da5ede299,
title = "Norethisterone acetate versus norethisterone acetate combined with letrozole for the treatment of ovarian endometriotic cysts: A patient preference study",
abstract = "Objective To compare the efficacy of norethisterone acetate (NETA; group N) or letrozole combined with NETA (group L) in treating endometriotic ovarian cysts. Study design This patient-preference study included 20 patients in group N and 20 patients in group L. The primary aim of the study was to compare the volume of the endometriomas during and after treatment. The secondary outcome was the evaluation of the changes in pain symptoms during and after treatment. Results After six months of treatment, the volume of the endometriomas significantly decreased compared with baseline in both study groups; it was smaller in group L than in group N (p = 0.026). The rate of satisfied patients at six months of treatment was similar between the study groups (p = 0.451). No significant difference was reported between the two study groups in the amelioration of pain symptoms and in the incidence of adverse events. Conclusions Letrozole combined with NETA is more efficacious than NETA alone in reducing the volume of endometriotic cysts but in none of the 40 patients included in the study did the endometriomas disappear. The efficacy of aromatase inhibitors, however, should be balanced with the need to administer long-term treatment.",
keywords = "Endometriotic ovarian cysts, Letrozole, Norethisterone, Patient satisfaction",
author = "Simone Ferrero and Valentino Remorgida and Venturini, {Pier Luigi} and {Leone Roberti Maggiore}, Umberto",
year = "2014",
doi = "10.1016/j.ejogrb.2013.11.030",
language = "English",
volume = "174",
pages = "117--122",
journal = "European Journal of Obstetrics, Gynecology and Reproductive Biology",
issn = "0028-2243",
publisher = "Elsevier Ireland Ltd",
number = "1",

}

TY - JOUR

T1 - Norethisterone acetate versus norethisterone acetate combined with letrozole for the treatment of ovarian endometriotic cysts

T2 - A patient preference study

AU - Ferrero, Simone

AU - Remorgida, Valentino

AU - Venturini, Pier Luigi

AU - Leone Roberti Maggiore, Umberto

PY - 2014

Y1 - 2014

N2 - Objective To compare the efficacy of norethisterone acetate (NETA; group N) or letrozole combined with NETA (group L) in treating endometriotic ovarian cysts. Study design This patient-preference study included 20 patients in group N and 20 patients in group L. The primary aim of the study was to compare the volume of the endometriomas during and after treatment. The secondary outcome was the evaluation of the changes in pain symptoms during and after treatment. Results After six months of treatment, the volume of the endometriomas significantly decreased compared with baseline in both study groups; it was smaller in group L than in group N (p = 0.026). The rate of satisfied patients at six months of treatment was similar between the study groups (p = 0.451). No significant difference was reported between the two study groups in the amelioration of pain symptoms and in the incidence of adverse events. Conclusions Letrozole combined with NETA is more efficacious than NETA alone in reducing the volume of endometriotic cysts but in none of the 40 patients included in the study did the endometriomas disappear. The efficacy of aromatase inhibitors, however, should be balanced with the need to administer long-term treatment.

AB - Objective To compare the efficacy of norethisterone acetate (NETA; group N) or letrozole combined with NETA (group L) in treating endometriotic ovarian cysts. Study design This patient-preference study included 20 patients in group N and 20 patients in group L. The primary aim of the study was to compare the volume of the endometriomas during and after treatment. The secondary outcome was the evaluation of the changes in pain symptoms during and after treatment. Results After six months of treatment, the volume of the endometriomas significantly decreased compared with baseline in both study groups; it was smaller in group L than in group N (p = 0.026). The rate of satisfied patients at six months of treatment was similar between the study groups (p = 0.451). No significant difference was reported between the two study groups in the amelioration of pain symptoms and in the incidence of adverse events. Conclusions Letrozole combined with NETA is more efficacious than NETA alone in reducing the volume of endometriotic cysts but in none of the 40 patients included in the study did the endometriomas disappear. The efficacy of aromatase inhibitors, however, should be balanced with the need to administer long-term treatment.

KW - Endometriotic ovarian cysts

KW - Letrozole

KW - Norethisterone

KW - Patient satisfaction

UR - http://www.scopus.com/inward/record.url?scp=84894229508&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84894229508&partnerID=8YFLogxK

U2 - 10.1016/j.ejogrb.2013.11.030

DO - 10.1016/j.ejogrb.2013.11.030

M3 - Article

VL - 174

SP - 117

EP - 122

JO - European Journal of Obstetrics, Gynecology and Reproductive Biology

JF - European Journal of Obstetrics, Gynecology and Reproductive Biology

SN - 0028-2243

IS - 1

ER -